Dunhill Financial’s AtriCure ATRC Stock Holding History

Dunhill Financial’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$34	–	1880
2025 Q4	$34	Buy	+1	New	+$37	﹤0.01%	1779

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dunhill Financial's ATRC Position: Q1 2026 in Review

Dunhill Financial sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 1 share — an estimated $34 sold.

Dunhill Financial first reported a position in ATRC in Q4 2025 and held it in 1 quarter. The position peaked at $34 in Q4 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

Dunhill Financial reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
Dunhill Financial sold 1 AtriCure share in Q1 2026, an estimated $34.
Dunhill Financial first reported a position in AtriCure in Q4 2025 and held it in 1 quarter.
Dunhill Financial's AtriCure position peaked at $34 in Q4 2025.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.